Fingerprint
Dive into the research topics of 'Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically